Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome

The Journal of Clinical Endocrinology and Metabolism
A DunaifA Dobrjansky

Abstract

Women with the polycystic ovary syndrome (PCO) have significant insulin resistance and are at risk to develop noninsulin-dependent diabetes mellitus. It remains controversial, however, whether hyperandrogenism directly decreases insulin action. Hence, we performed 2-h euglycemic glucose (approximately 772 pmol/L steady state insulin levels) clamps in nine PCO women with insulin resistance basally and after the 12th week of therapy with a superagonist GnRH analog (40 micrograms every 8 h, sc). Diet, activity, and weight were kept constant. Despite significant decreases in plasma testosterone and androstenedione levels (both P less than 0.05), there was no significant change in insulin-mediated glucose disposal, plasma insulin levels, or hepatic glucose production. The sample size was adequate to detect a clinically significant change in insulin-stimulated glucose disposal (i.e. approximately 3.3 mumol/kg.min; P less than or equal to 0.05). We conclude that suppressing androgen levels into the normal range did not result in significant changes in insulin resistance in PCO. Thus, controlling hyperandrogenemia is not a clinically effective modality to improve insulin action and thereby decrease the risk of noninsulin-dependent diab...Continue Reading

Citations

Jan 1, 1995·Lasers in Surgery and Medicine·E M KaaijkF van der Veen
Jul 1, 1993·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D MeirowJ G Schenker
Mar 12, 2004·Metabolism: Clinical and Experimental·Marzieh SalehiLeonid Poretsky
Jun 12, 2002·Fertility and Sterility·Fernando Ovalle, Ricardo Azziz
Aug 12, 2003·Fertility and Sterility·Rogerio A Lobo
Aug 12, 2003·Fertility and Sterility·Imran Pirwany, Togas Tulandi
Oct 16, 1999·Fertility and Sterility·A M PaolettiG B Melis
Jun 3, 1999·Endocrinology and Metabolism Clinics of North America·A Dunaif
Apr 1, 1996·Baillière's Clinical Endocrinology and Metabolism·J Holte
Aug 1, 1995·Ceská gynekologie·J Zivný
Jan 9, 2008·Seminars in Reproductive Medicine·Pinar H Kodaman, Antoni J Duleba
Sep 26, 1991·The New England Journal of Medicine·D E Moller, J S Flier
Sep 28, 1995·The New England Journal of Medicine·S Franks
Oct 14, 2010·Metabolic Syndrome and Related Disorders·Andrew A Bremer
Dec 1, 1993·Clinical Endocrinology·G S Conway, H S Jacobs
Aug 1, 1996·British Journal of Obstetrics and Gynaecology·X K WuZ X Zhang
Dec 16, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·C J KellyH Lyall
Mar 1, 1994·American Journal of Reproductive Immunology : AJRI·M H GoniG Tolis
Sep 9, 2011·International Journal of Pediatric Endocrinology·David H GellerUNKNOWN of the Drug and Therapeutics Committee of the Pediatric Endocrine Society
Dec 3, 2015·Current Obesity Reports·Thomas S Paterakis, Evanthia Diamanti-Kandarakis
Jul 6, 2010·Women's Health·Alessandro D GenazzaniChiara Lanzoni
Jan 18, 2007·Der Internist·D HeutlingH Lehnert
Oct 15, 2005·Pediatric Annals·Amy Fleischman, Joan Mansfield
Aug 19, 2007·Trends in Endocrinology and Metabolism : TEM·Héctor F Escobar-Morreale, José L San Millán
Jun 15, 2007·Fertility and Sterility·Jean-Patrice Baillargeon, André Carpentier
Sep 9, 2006·Endocrinology and Metabolism Clinics of North America·Preethi SrikanthanSusan Davis
Dec 18, 2003·Clinical Endocrinology·Tasoula TsilchorozidouGerard S Conway
Jun 6, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·Vinod K Patel, Huw Alban Davies
Feb 12, 2005·Fertility and Sterility·Jeffrey B SchwimmerWalter B Schwimmer
Apr 1, 1995·Metabolism: Clinical and Experimental·E Diamanti-KandarakisS Raptis
Jul 21, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Avi Ben-HaroushBenjamin Fisch
Aug 12, 2006·Fertility and Sterility·Dijana HadziomerovićLudwig Wildt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.